Simultaneous analysis of clinicopathological parameters of other patient groups revealed that CD44 is also involved in local aggressive HCC recurrence through regulation of EMT genes (including low E-cadherin, high vimentin, and high N-cadherin expression) after local ablation therapy (LAT) [90]. This evidence concerns the gene CD44 and hepatocellular carcinoma.